- In May 2023, Hyderabad-based MSN Labs has introduced Fesobig, the world's first bioequivalent generic version of Fesoterodine Fumarate. This medication is endorsed as the safest and most innovative first-line pharmacotherapy option by numerous international treatment guidelines for managing overactive bladder (OAB) and urinary incontinence (UI)
